Noncontraceptive Estrogens and Abnormalities of Endometrial Proliferation
- 28 February 1978
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 88 (3) , 410-412
- https://doi.org/10.7326/0003-4819-88-3-410
Abstract
Use of estrogen preparations among menopausal women has been causally associated with the development of hyperplasia and adenocarcinoma of the endometrium. The magnitude of the association seems to be greater for the hyperplastic and least aggressive malignant lesions, and smaller for tumors of higher stage and grade. This observed inverse relation of estrogen use to degree of malignancy is probably due to relatively early or overly liberal diagnoses of endometrial cancer among estrogen users, but could mean that estrogens promote less aggressive tumors. It appears the current increased incidence of endometrial cancer in the USA will not be followed by a corresponding increase in mortality from the disease.Keywords
This publication has 7 references indexed in Scilit:
- Estrogen and Endometrial CarcinomaNew England Journal of Medicine, 1977
- Exogenous estrogen and endometrial carcinoma: Case-control and incidence studyAmerican Journal of Obstetrics and Gynecology, 1977
- ENDOMETRIAL CANCER ASSOCIATED WITH FEMINIZING OVARIAN TUMOR AND POLYCYSTIC OVARIAN DISEASE1977
- Estrogens and Endometrial Cancer in a Retirement CommunityNew England Journal of Medicine, 1976
- Increasing Incidence of Endometrial Cancer in the United StatesNew England Journal of Medicine, 1976
- CANCER OF THE UTERINE CORPUS AFTER HORMONAL TREATMENT FOR BREAST CANCERThe Lancet, 1976
- ESTROGENS AND ENDOMETRIAL CANCER - ASPECTS OF ETIOLOGY AND SURVIVAL RATE1976